Skip to main content

Table 3 Drug treatment registered at baseline (before change) by class

From: The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy

Monotherapy (n = 186) Co-therapy with 2 drugs (n = 150) Polytherapy (> 2 drugs) (n = 135)
Drug N (%) Drugs N (%) Drugs N (%)
Haloperidol 45 (24.2) Other typical/atypical 15 (10.0) Haloperidol/other typicals/other AC 11 (8.2)
Valproate 31 (16.7) Haloperidol/Lithium 12 (8.0) Haloperidol/other typicals/Valproate 11 (8.2)
Lithium 27 (14.5) Olanzapine/Valproate 10 (6.7) Haloperidol/other typicals/Lithium 8 (5.9)
Olanzapine 19 (10.2) Risperidone/non-valproate AC 10 (6.7) Other typicals/other AC/Lithium 8 (5.9)
Other typical 18 (9.7) Other typical/Valproate 10 (6.7) Haloperidol/other typicals 3 (2.2)
Risperidone 16 (8.6) Risperidone/Lithium 9 (6.0) Other typicals/Valproate/Lithium 2 (1.5)
Other AC 14 (7.6) 2 typicals 9 (6.0) Other combinations 92 (68.1)
Quetiapine 10 (5.4) Other typical/Lithium 8 (5.3)   
Other atypical 6 (3.2) Haloperidol/Valproate 8 (5.3)   
   Lithium/non-valproate AC 8 (5.3)   
   Olanzapine/Lithium 7 (4.7)   
   Haloperidol/non-valproate AC 7 (4.7)   
   Other combinations 37 (24.7)   
  1. AC = Anticonvulsivants;